These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38295989)

  • 1. Anti-GM-CSF autoantibodies predict outcome of cryptococcal meningitis in patients not infected with HIV: A cohort study.
    Jiang YK; Zhou LH; Cheng JH; Zhu JH; Luo Y; Li L; Zhu M; Zhu RS; Qiu WJ; Zhao HZ; Wang X; Huang JT; Cornely OA; Zhang WH; Zhu LP
    Clin Microbiol Infect; 2024 May; 30(5):660-665. PubMed ID: 38295989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients.
    Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ
    mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies Neutralizing GM-CSF in HIV-Negative Colombian Patients Infected with Cryptococcus gattii and C. neoformans.
    Arango-Franco CA; Rojas J; Firacative C; Migaud M; Agudelo CI; Franco JL; Casanova JL; Puel A; Lizarazo J; Castañeda E; Arias AA
    J Clin Immunol; 2024 Jul; 44(7):163. PubMed ID: 39008214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
    Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
    J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis.
    Rosen LB; Freeman AF; Yang LM; Jutivorakool K; Olivier KN; Angkasekwinai N; Suputtamongkol Y; Bennett JE; Pyrgos V; Williamson PR; Ding L; Holland SM; Browne SK
    J Immunol; 2013 Apr; 190(8):3959-66. PubMed ID: 23509356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-GM-CSF Neutralizing Autoantibodies in Colombian Patients with Disseminated Cryptococcosis.
    Arango-Franco CA; Migaud M; Ramírez-Sánchez IC; Arango-Bustamante K; Moncada-Vélez M; Rojas J; Gervais A; Patiño-Giraldo S; Perez-Zapata LJ; Álvarez Álvarez JA; Orrego JC; Roncancio-Villamil G; Boisson-Dupuis S; Jouanguy E; Abel L; Casanova JL; Bustamante J; Arias AA; Franco JL; Puel A
    J Clin Immunol; 2023 Jul; 43(5):921-932. PubMed ID: 36821021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii.
    Van TT; Kim TH; Butler-Wu SM
    Clin Microbiol Infect; 2020 Oct; 26(10):1375-1379. PubMed ID: 31972318
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Applen Clancey S; Ciccone EJ; Coelho MA; Davis J; Ding L; Betancourt R; Glaubiger S; Lee Y; Holland SM; Gilligan P; Sung J; Heitman J
    mBio; 2019 Feb; 10(1):. PubMed ID: 30755511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies neutralizing GM-CSF in HIV-negative Colombian patients infected with Cryptococcus gattii and C. neoformans.
    Arango-Franco CA; Rojas J; Firacative C; Agudelo CI; Franco JL; Casanova JL; Puel A; Lizarazo J; Castañeda E; Arias AA
    Res Sq; 2024 Jan; ():. PubMed ID: 38313298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pathogenic Role of Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Nocardiosis with the Central Nervous System Involvement.
    Lo YF; Wang SY; Wu YH; Ho MW; Yeh CF; Wu TY; Peng JJ; Lin YN; Ding JY; Shih HP; Lo CC; Chan YP; Rau CS; Kuo CY; Tu KH; Lei WT; Chen YC; Ku CL
    J Clin Immunol; 2024 Aug; 44(8):176. PubMed ID: 39133333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor.
    Wang SY; Lo YF; Shih HP; Ho MW; Yeh CF; Peng JJ; Ting HT; Lin KH; Huang WC; Chen YC; Chiu YH; Hsu CW; Tseng YT; Wang LS; Lei WY; Lin CY; Aoh Y; Chou CH; Wu TY; Ding JY; Lo CC; Lin YN; Tu KH; Lei WT; Kuo CY; Chi CY; Ku CL
    J Clin Immunol; 2022 Nov; 42(8):1730-1741. PubMed ID: 35947322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcus gattii Species Complex as an Opportunistic Pathogen: Underlying Medical Conditions Associated with the Infection.
    Yang DH; England MR; Salvator H; Anjum S; Park YD; Marr KA; Chu LA; Govender NP; Lockhart SR; Desnos-Ollivier M; Chen S; Halliday C; Kan A; Chen J; Wollenberg KR; Zelazny A; Perfect JR; Chang YC; Bennett JE; Holland SM; Meyer W; Williamson PR; Kwon-Chung KJ
    mBio; 2021 Oct; 12(5):e0270821. PubMed ID: 34700378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralizing Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Patients With Central Nervous System and Localized Cryptococcosis: Longitudinal Follow-up and Literature Review.
    Kuo PH; Wu UI; Pan YH; Wang JT; Wang YC; Sun HY; Sheng WH; Chen YC; Chang SC
    Clin Infect Dis; 2022 Aug; 75(2):278-287. PubMed ID: 34718451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: An underappreciated association.
    Viola GM; Malek AE; Rosen LB; DiNardo AR; Nishiguchi T; Okhuysen PC; Holland SM; Kontoyiannis DP
    Mycoses; 2021 Jun; 64(6):576-582. PubMed ID: 33476401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-hospital mortality of HIV-infected cryptococcal meningitis patients with C. gattii and C. neoformans infection in Gaborone, Botswana.
    Steele KT; Thakur R; Nthobatsang R; Steenhoff AP; Bisson GP
    Med Mycol; 2010 Dec; 48(8):1112-5. PubMed ID: 20438294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis.
    Robertson EJ; Najjuka G; Rolfes MA; Akampurira A; Jain N; Anantharanjit J; von Hohenberg M; Tassieri M; Carlsson A; Meya DB; Harrison TS; Fries BC; Boulware DR; Bicanic T
    J Infect Dis; 2014 Jan; 209(1):74-82. PubMed ID: 23945372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Cryptococcus gattii in Ugandan HIV-infected patients presenting with cryptococcal meningitis.
    Wembabazi A; Nassozi DR; Akot E; Ochola TI; Kweka PT; Katamu NT; Meya D; Achan B
    PLoS One; 2022; 17(7):e0270597. PubMed ID: 35839221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of quantitative PCR assays for HIV-associated cryptococcal meningitis in sub-Saharan Africa: a diagnostic accuracy study.
    Mbangiwa T; Sturny-Leclère A; Lechiile K; Kajanga C; Boyer-Chammard T; Hoving JC; Leeme T; Moyo M; Youssouf N; Lawrence DS; Mwandumba H; Mosepele M; Harrison TS; Jarvis JN; Lortholary O; Alanio A;
    Lancet Microbe; 2024 Mar; 5(3):e261-e271. PubMed ID: 38342110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic distribution of patients affected by Cryptococcus neoformans/Cryptococcus gattii species complexes meningitis, pigeon and tree populations in Southern Brazil.
    Spina-Tensini T; Muro MD; Queiroz-Telles F; Strozzi I; Moraes ST; Petterle RR; Vettorello M; Staudacher C; Miguez LA; de Almeida SM
    Mycoses; 2017 Jan; 60(1):51-58. PubMed ID: 27561904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum cryptococcal antigen titre as a diagnostic tool and a predictor of mortality in HIV-infected patients with cryptococcal meningitis.
    Chen J; Zhang R; Shen Y; Liu L; Qi T; Wang Z; Mehraj V; Routy JP; Lu H
    HIV Med; 2019 Jan; 20(1):69-73. PubMed ID: 30311440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.